Syndax Pharmaceuticals
SNDX
SNDX
215 hedge funds and large institutions have $948M invested in Syndax Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 84 increasing their positions, 67 reducing their positions, and 30 closing their positions.
Holders
215
Holders Change
-3
Holders Change %
-1.38%
% of All Funds
2.89%
Holding in Top 10
7
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-30%
% of All Funds
0.09%
New
31
Increased
84
Reduced
67
Closed
30
Calls
$12.8M
Puts
$10.1M
Net Calls
+$2.68M
Net Calls Change
-$7.5M
Top Buyers
1 |
1
BlackRock
New York
|
$97.9M |
2 |
2
Goldman Sachs
New York
|
$54.3M |
3 |
3
Millennium Management
New York
|
$15M |
4 |
4
Bank of America
Charlotte,
North Carolina
|
$36M |
5 |
5
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$15.6M |